alpha-methyltyrosine methyl ester has been researched along with Substance Withdrawal Syndrome in 1 studies
alpha-methyltyrosine methyl ester: RN given refers to parent cpd
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McDougall, SA | 1 |
| Hernandez, RM | 1 |
| Reichel, CM | 1 |
| Farley, CM | 1 |
1 other study available for alpha-methyltyrosine methyl ester and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
The partial D2-like dopamine receptor agonist terguride acts as a functional antagonist in states of high and low dopaminergic tone: evidence from preweanling rats.
Topics: Animals; Animals, Newborn; Apomorphine; Body Weight; Corpus Striatum; Dextroamphetamine; Dopamine; D | 2005 |